By Athena Vlachou
Drugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer’s disease in mice, a study led by the Cyprus Institute of Neurology and Genetics (CING) shows, but the timing and length of treatment may be key to achieving comparable results in humans.
The August 2025 study, published in the journal ‘Frontiers in Neuroscience’ , shows that two FDA-approved drugs, Alirocumab, which modulates
